The CDC and FDA released information this morning that they are reviewing data involving a rare type of blood clot that has been reported in six out of 6.8 million individuals who have received the Johnson & Johnson (Janssen) vaccine. They, along with the NC Department of Health and Human Services and the UNC System, have recommended a pause in the use of the vaccine until they can better evaluate the data. The full CDC and FDA statement can be found here. As a result, we will not be administering the Johnson & Johnson vaccine in our on-campus clinic until further notice.
A few important things to know:
- At this point, there are 6 known cases of this happening out of 6.8 million people, indicating that this is a very rare adverse reaction.
- The pause will allow the CDC and FDA to better understand why this may be happening and provide guidance to the medical community.
- This pause is not related to the temporary pause in the use of the Johnson & Johnson vaccine in Wake County and at UNC last week.
- The pause and related concerns apply only to the Johnson & Johnson vaccine; there is no evidence that this is a concern for the Moderna or Pfizer vaccines. Accordingly, UNCG clinics scheduled for this week to administer second doses of Moderna and Pfizer will be held as scheduled.
- The identification of this very rare adverse event indicates that the systems that have been put in place to monitor adverse reactions are working.
We will provide updates as additional information and guidance becomes available. Getting vaccinated remains a critically important part of our fight against the pandemic. As always, if you have any questions or concerns related to your own experience with getting vaccinated, please contact your healthcare provider.